Anjali Vaidya, MD, FACC, FASE, FACP, Co-Director of Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple Health shares advanced diagnosis and managment for chronic thromboembolic pulmonary hypertension.

Dr. Vaidya reviews:

• Pathogenisis, epidemiology, and risk factors
• Diagnostic criteria and evaluation
• Pulmonary thromboendarterectomy (PTE)
• Balloon pulmonary angioplasty (BPA)
• Medical Therapy
• Conditions CTEPH mimics

The Pulmonary Hypertension, Right Heart Failure, and CTEPH Program at Temple Health has conducted more than 350 PTEs, and has achieved a 100% survival rate in the last year (2021-2022).